Ligand · KEU
KEU · N-{4-[(1R)-4-[(2R,4R,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]benzoyl}-D-glutamic acid
KEU, N-{4-[(1R)-4-[(2R,4R,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]benzoyl}-D-glutamic acid (C22 H30 F3 N5 O8, 549.5 g/mol), in the MolNFT structures on GenesisL1: bound in 6 records (3 PDB…
- Component
- KEU
- Formula
- C22 H30 F3 N5 O8
- Class
- ligand
- Structures
- 6
- PDB entries
- 3
Binding sites
KEU in 6 structures; the first of them:
- 1NJS · human GAR Tfase in complex with hydrolyzed form of… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
- 1RBQ · Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-te… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
- 1RBY · Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-te… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
- 1NJS · Human gar tfase in complex with hydrolyzed form of 10… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
- 1RBQ · Human gar tfase complex structure with 10-(trifluoroacetyl)… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
- 1RBY · Human gar tfase complex structure with 10-(trifluoroacetyl)… · KEU A510 · binds ARG64, LEU85, PHE88, MET89, ARG90, ILE91, LEU92, VAL97 and 13 more
Residues it binds most
VAL 20, LEU 20, ARG 20, ASP 20, HIS 20, ILE 20, GLU 20, ALA 20, ASN 20, GLY 20 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.